AvKARE Rosuvastatin 10 mg tablets recalled for dissolution defect
AvKARE is recalling Rosuvastatin 10 mg tablets (Lot #49124, expiring 12/31/2026) because they don't dissolve properly in the body. This means the medication may not work as intended. No injuries have been reported so far.
From the FDA notice · Read the official notice ↗ · All AvKARE recalls
What to do
- Check if you have this medication: NDC 50268-709-15, Lot #49124, expiration date 12/31/2026
- Stop taking the affected tablets
- Contact your pharmacy or doctor for a replacement prescription
- Do not flush or throw away the medication; ask your pharmacy how to safely return or dispose of it
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Rosuvastatin Tablets, USP, 10 mg, Rx Only, 50 Tablets (5 x 10) Unit Dose per carton, Manufactured for: AvKARE, Pulaski, TN 38478. NDC: 50268-709-15
- Sold in
- Nationwide
- Made for
- Adults (0 months and older)
Details
- Units affected
- 7,991 5x10 cartons
- Illnesses reported
- None reported
- Manufactured in
- 615 N 1st St, Pulaski, TN, United States
- Classification
- Class II
- Recall number
- D-0292-2026
In the FDA's words
- Description
- Rosuvastatin Tablets, USP, 10 mg, Rx Only, 50 Tablets (5 x 10) Unit Dose per carton, Manufactured for: AvKARE, Pulaski, TN 38478. NDC: 50268-709-15 Out of specification for dissolution. Lot #49124, Exp Date 12/31/2026 Distribution: Nationwide in the USA Affected quantity: 7,991 5x10 cartons
- Hazard
- Out of specification for dissolution.
More from AvKARE
See all- AvKARE fludrocortisone tablets recalled over impurity levels
ModerateFDAOct 30, 2026
- AvKARE amitriptyline tablets recalled for failed dissolution
ModerateFDAOct 28, 2026